Metastatic Prostate Cancer in a RAD51C Mutation Carrier

Clinical Medicine and Research - United States
doi 10.3121/cmr.2018.1411
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marshfield Clinic Research Foundation

Related search

Expanding Horizons in Metastatic Prostate Cancer Treatment

Nature Reviews Clinical Oncology
Oncology
2011English

MicroRNA-186 and Metastatic Prostate Cancer.

English

Impact of Tumor Cytoreduction in Metastatic Prostate Cancer

Research and Reports in Urology
Urology
2019English

‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

A Case of Metastatic Prostate Cancer and Immune Thrombocytopenia

Current Oncology
Oncology
2017English

Prostate Cancer Predisposition Loci and Risk of Metastatic Disease and Prostate Cancer Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2011English

Stat3 Promotes Metastatic Progression of Prostate Cancer

American Journal of Pathology
Forensic MedicinePathology
2008English

Authors' Reply: Expanding Horizons in Metastatic Prostate Cancer Treatment

Nature Reviews Clinical Oncology
Oncology
2011English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy